Douglas C. Lane & Associates’s Celgene Corp CELG Stock Holding History

Douglas C. Lane & Associates’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$38.7M	Sell	322,963 -4,203	-1%	-$486K	1.05%	34
2015 Q3	$35.4M	Sell	327,166 -12,732	-4%	-$1.58M	1.01%	34
2015 Q2	$39.3M	Sell	339,898 -6,404	-2%	-$732K	1.06%	32
2015 Q1	$39.9M	Buy	346,302 +1,643	+0.5%	+$196K	1.05%	32
2014 Q4	$38.6M	Buy	344,659 +3,542	+1%	+$374K	1.04%	33
2014 Q3	$32.3M	Buy	341,117 +10,838	+3%	+$978K	0.96%	41
2014 Q2	$28.4M	Buy	330,279 +112,441	+52%	+$8.55M	0.86%	49
2014 Q1	$15.2M	Buy	217,838 +81,088	+59%	+$6.42M	0.49%	74
2013 Q4	$11.6M	Buy	136,750 +56,800	+71%	+$4.49M	0.38%	88
2013 Q3	$6.16M	Buy	79,950 +51,120	+177%	+$3.58M	0.22%	101
2013 Q2	$1.69M	Buy	+28,830	New	+$1.73M	0.07%	127

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Douglas C. Lane & Associates's CELG Position: Q4 2015 in Review

Douglas C. Lane & Associates reduced its Celgene Corp (CELG) stake by 1.3% in Q4 2015, selling an estimated $486K and leaving 322,963 shares worth $38.7M. The position accounts for 1.05% of the portfolio, ranked #34.

Douglas C. Lane & Associates first reported a position in CELG in Q2 2013 and has held it in 11 quarters since. The position peaked at $39.9M in Q1 2015. 1,246 funds tracked by Wall St. Rank hold CELG as of Q4 2015.

Douglas C. Lane & Associates held 322,963 shares of Celgene Corp worth $38.7M as of Q4 2015.
Douglas C. Lane & Associates sold 4,203 Celgene Corp shares in Q4 2015, an estimated $486K.
Celgene Corp made up 1.05% of Douglas C. Lane & Associates's portfolio in Q4 2015, its #34 holding.
Douglas C. Lane & Associates first reported a position in Celgene Corp in Q2 2013 and has held it in 11 quarters since.
Douglas C. Lane & Associates's Celgene Corp position peaked at $39.9M in Q1 2015.
1,246 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2015.

Based on Douglas C. Lane & Associates's 13F filing for Q4 2015, filed 25 Jan 2016.